CONTEXT: Mothers who exclusively breastfeed lose up to 10% of their bone mass. This is primarily mediated by PTHrP, in combination with low estrogen levels. The mechanisms underlying this marked bone loss are unknown. Uncoupling of bone turnover, which is seen in other prototypical states of bone loss, would seem the likely explanation. However, the most current markers of bone turnover have not been studied in human lactation. OBJECTIVES: The purpose of this study was to assess bone formation in lactating humans using the most current bone turnover markers. DESIGN AND PARTICIPANTS: We conducted a prospective cohort study with repeated measures of bone metabolism in a volunteer sample of 49 women, recruited into three study groups: lactating, bottle feeding, and healthy controls. The postpartum women were studied at 6-8 and 12-14 wk postpartum, whereas the controls were studied at the follicular phase of their menstrual cycles. OUTCOME MEASURES: Biochemical markers of bone turnover were assessed. RESULTS: Mean serum C-telopeptide of type I collagen, a sensitive marker of bone resorption, was approximately 2-fold higher in lactating women as compared with bottle-feeding and healthy controls (P = 0.037 and P < 0.001, respectively). Surprisingly, amino-terminal telopeptides of procollagen 1, the most current marker of bone formation, bone-specific alkaline phosphatase, and osteocalcin were all significantly higher in the lactating group as compared with controls (P < 0.001, P = 0.002, and P < 0.001, respectively). CONCLUSIONS: In contrast to prototypical states of rapid bone loss (myeloma, cancer, and immobilization) in which markers of bone turnover display marked uncoupling, lactational bone loss, as assessed in this small exploratory study, is distinct, showing comparably rapid bone loss in the face of apparent osteoclast-osteoblast coupling.
CONTEXT: Mothers who exclusively breastfeed lose up to 10% of their bone mass. This is primarily mediated by PTHrP, in combination with low estrogen levels. The mechanisms underlying this marked bone loss are unknown. Uncoupling of bone turnover, which is seen in other prototypical states of bone loss, would seem the likely explanation. However, the most current markers of bone turnover have not been studied in humanlactation. OBJECTIVES: The purpose of this study was to assess bone formation in lactating humans using the most current bone turnover markers. DESIGN AND PARTICIPANTS: We conducted a prospective cohort study with repeated measures of bone metabolism in a volunteer sample of 49 women, recruited into three study groups: lactating, bottle feeding, and healthy controls. The postpartum women were studied at 6-8 and 12-14 wk postpartum, whereas the controls were studied at the follicular phase of their menstrual cycles. OUTCOME MEASURES: Biochemical markers of bone turnover were assessed. RESULTS: Mean serum C-telopeptide of type I collagen, a sensitive marker of bone resorption, was approximately 2-fold higher in lactating women as compared with bottle-feeding and healthy controls (P = 0.037 and P < 0.001, respectively). Surprisingly, amino-terminal telopeptides of procollagen 1, the most current marker of bone formation, bone-specific alkaline phosphatase, and osteocalcin were all significantly higher in the lactating group as compared with controls (P < 0.001, P = 0.002, and P < 0.001, respectively). CONCLUSIONS: In contrast to prototypical states of rapid bone loss (myeloma, cancer, and immobilization) in which markers of bone turnover display marked uncoupling, lactational bone loss, as assessed in this small exploratory study, is distinct, showing comparably rapid bone loss in the face of apparent osteoclast-osteoblast coupling.
Authors: H N Rosen; A C Moses; J Garber; I D Iloputaife; D S Ross; S L Lee; S L Greenspan Journal: Calcif Tissue Int Date: 2000-02 Impact factor: 4.333
Authors: Mara J Horwitz; Mary Beth Tedesco; Susan M Sereika; Bruce W Hollis; Adolfo Garcia-Ocaña; Andrew F Stewart Journal: J Clin Endocrinol Metab Date: 2003-04 Impact factor: 5.958
Authors: M A Syed; M J Horwitz; M B Tedesco; A Garcia-Ocaña; S R Wisniewski; A F Stewart Journal: J Clin Endocrinol Metab Date: 2001-04 Impact factor: 5.958
Authors: Joshua N VanHouten; Pamela Dann; Andrew F Stewart; Christine J Watson; Michael Pollak; Andrew C Karaplis; John J Wysolmerski Journal: J Clin Invest Date: 2003-11 Impact factor: 14.808
Authors: Carol L Wagner; Bruce W Hollis; Kalliopi Kotsa; Hana Fakhoury; Spyridon N Karras Journal: Rev Endocr Metab Disord Date: 2017-09 Impact factor: 6.514
Authors: Raquel M Carneiro; Linda Prebehalla; Mary Beth Tedesco; Susan M Sereika; Caren M Gundberg; Andrew F Stewart; Mara J Horwitz Journal: J Clin Endocrinol Metab Date: 2012-12-28 Impact factor: 5.958
Authors: Sheila Bornstein; Sue A Brown; Phuong T Le; Xunde Wang; Victoria DeMambro; Mark C Horowitz; Ormond MacDougald; Roland Baron; Sutada Lotinun; Gerard Karsenty; Wei Wei; Mathieu Ferron; Christopher S Kovacs; David Clemmons; Yihong Wan; Clifford J Rosen Journal: Endocrinology Date: 2014-06-10 Impact factor: 4.736